VLDLR antibody (AA 231-770)
Quick Overview for VLDLR antibody (AA 231-770) (ABIN7872569)
Target
See all VLDLR AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 231-770
-
Purpose
- VLDL Receptor Antibody / VLDLR
-
Purification
- Antigen affinity purified
-
Immunogen
- Recombinant human protein (amino acids R231-S770) was used as the immunogen for the VLDL Receptor antibody.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal dilution of the VLDL Receptor antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- After reconstitution, the VLDL Receptor antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- VLDLR (Very Low Density Lipoprotein Receptor (VLDLR))
-
Alternative Name
- VLDL Receptor
-
Background
- The very-low-density-lipoprotein receptor (VLDLR) is a transmembrane lipoprotein receptor of the low-density-lipoprotein (LDL) receptor family. The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. This gene encodes a lipoprotein receptor that is a member of the LDLR family and plays important roles in VLDL-triglyceride metabolism and the reelin signaling pathway. Mutations in this gene cause VLDLR-associated cerebellar hypoplasia. Alternative splicing generates multiple transcript variants encoding distinct isoforms for this gene.
-
UniProt
- P98155
-
Pathways
- Cellular Response to Molecule of Bacterial Origin
Target
-